|
2024
|
Invention
|
Trans-cyclooctene-modified targeted protein degrader conjugates. The present disclosure relates g... |
|
|
Invention
|
Tetrazine-based targeting agents for in vivo delivery of a payload. The present disclosure relate... |
|
|
Invention
|
Trans-cyclooctene conjugates. The present disclosure relates generally trans-cyclooctene conjugat... |
|
|
Invention
|
System comprising modified whole cell payloads for targeted delivery. The present disclosure rela... |
|
2022
|
Invention
|
Trans-cyclooctene-modified bispecific antibodies.
The present disclosure relates generally to tr... |
|
|
Invention
|
Trans-cyclooctene-modified bispecific antibodies. The present disclosure relates generally to tra... |
|
|
Invention
|
Tetrazine conjugates for in vivo targeted delivery of a payload. The present disclosure relates g... |
|
2021
|
Invention
|
Bioorthogonal compositions.
The present disclosure provides bioorthogonal compositions for deliv... |
|
|
Invention
|
Bioorthogonal compositions.
Cyclooctene conjugates of therapeutic or diagnostic agents have impr... |
|
|
Invention
|
Trans-cyclooctene bioorthogonal agents and uses in cancer and immunotherapy.
Trans-cyclooctene c... |
|
|
Invention
|
Trans-cyclooctene bioorthogonal agents and uses in cancer and immunotherapy. Trans-cyclooctene co... |
|
2020
|
G/S
|
Providing scientific research information in the field of pharmaceuticals |
|
|
G/S
|
Pharmaceutical preparations that are activated by click chemistry for the treatment of cancer, on... |
|
|
G/S
|
Pharmaceutical research and development; Scientific research in the field of pharmaceuticals, med... |
|
2019
|
Invention
|
Processes for preparing functionalized cyclooctenes. The present disclosure relates to processes ... |
|
2016
|
Invention
|
Bioorthogonal compositions. The present disclosure provides bioorthogonal compositions for delive... |
